elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q47718879-CF3715AB-EFC5-4C95-ADAA-BB380645EB3C
Q47718879-CF3715AB-EFC5-4C95-ADAA-BB380645EB3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47718879-CF3715AB-EFC5-4C95-ADAA-BB380645EB3C
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations.
P2093
Q47718879-CF3715AB-EFC5-4C95-ADAA-BB380645EB3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47718879-CF3715AB-EFC5-4C95-ADAA-BB380645EB3C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
007dbf092d919e056c3a2b1dcea1e6ec1e52f85c
P1545
1
http://www.w3.org/2001/XMLSchema#string
P2093
Jun Gong
http://www.w3.org/2001/XMLSchema#string